Replies to post #122249 on Bergio International Inc (BRGO)

[Squirrely_McShitty]

This is what I would call "good new debt". Commendable debt, in fact!

On June 16, 2022, the Company received proceeds related to a loan with Trillium Partners LP in the amount of $100,000. The loan and accrued interest were due on demand. Interest accrues at the rate of 3% per annum. As of June 30, 2022, the principal balance and accrued interest is $100,000 and $307, respectively.

This is what I would call toxic debt ...12%/22% default interest with option to convert at 75%. This is debt taken out in Q2 when we were supposedly done with this type of financing. One may argue we knew about this debt already (did we ... can't recall for sure ... think so) & they have made payments, but if we define "new" as in "filing from last week", this is new debt, just as the above is.

On April 13, 2022, the Company entered into a 12% promissory note in the amount of $127,400 less original issue discount of $13,650 and legal and financing costs of $3,750 for net proceeds of $110,000 with Sixth Street Lending, LLC. The principal and accrued interest is payable on or before April 13, 2023. Any amount of principal or interest on this note which is not paid when due shall bear interest at the rate of twenty two percent (22%) per annum from the due date thereof until the same is paid. Accrued, unpaid Interest and outstanding principal, subject to adjustment, shall be paid in ten (10) payments each in the amount of $14,268.80 (a total payback to the Holder of $142,688.). The first payment shall be due May 30, 2022 with nine (9) subsequent payments each month thereafter. The Company shall have a five (5) day grace period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty. At any time following an Event of Default, the Holder shall have the right, to convert all or any part of the outstanding and unpaid amount of this Note into shares of Common Stock. The conversion price shall mean 75% multiplied by the lowest Trading Price for the Common Stock during the ten (10) Trading Days prior to the Conversion Date (representing a discount rate of 25%). For the three and six months ended June 30, 2022, amortization of debt discounts related to this promissory note amounted to $3,718 for both periods which has been amortized and included in amortization of debt discount and deferred financing cost on the accompanying unaudited condensed consolidated statements of operations. During the six months ended June 30, 2022, the Company has repaid back $25,480 related to this promissory note. The outstanding balance at June 30, 2022 was $101,920 with accrued interest of $764.

[Squirrely_McShitty]

Upon rereading my original post, I didn't really answer your question.

In part it was written poorly. Most of the debt I see they have on the books is at less than favorable terms & exceeds inventory on hand, which was the point I was attempting to make vis-à-vis valuation...

That's difficult to argue with. One could argue they have $3m in inventory & should be worth at least that much (writing off the accumulated deficit & back CEO pay), but with the new debt they have taken out (most stock-based & at toxic terms) that eats that $3m up.

The new Series D shares sold, along with the additional 750m warrents for common stock, is not helpful either.

But aside from the Series D, which I don't believe can be termed "toxic financing" (or can it ... I'm no expert), I was incorrect in stating that the majority of the "toxic debt" $BRGO holds is "new".

That statement was my bad, and I am honestly not sure at this point why I phrased things that way. I assure everyone it wasn't purposeful.